30-Day and 1-Year Outcomes of Navitor Transcatheter Aortic Valve in Low- or Intermediate-Risk Patients
The Navitor valve demonstrated favorable safety and performance outcomes at 12 months, supporting its expansion to low- and intermediate-risk populations.
Authors
- Nicolas M. Van Mieghem (ORCID: https://orcid.org/0000-0002-2732-1205)
- Federico De Marco (ORCID: https://orcid.org/0000-0003-3554-6938)
- Helge Möllmann (ORCID: https://orcid.org/0000-0002-6047-0990)
- Ole De Backer (ORCID: https://orcid.org/0000-0002-9674-0278)
- Hai-Chien Kuo
- Antony Walton (ORCID: https://orcid.org/0000-0002-9173-5904)
- Nicola Corcione (ORCID: https://orcid.org/0000-0001-7137-274X)
- Maurizio Taramasso (ORCID: https://orcid.org/0000-0001-7295-1153)
- Francesco Bedogni (ORCID: https://orcid.org/0000-0002-4975-6605)
- Luis Nombela-Franco y (ORCID: https://orcid.org/0000-0003-3438-8907)
- Lionel Leroux (ORCID: https://orcid.org/0000-0003-2269-8449)
- Lihua Li (ORCID: https://orcid.org/0000-0001-5982-8441)
- Didier Tchétché (ORCID: https://orcid.org/0000-0001-7243-9408)
- Ganesh Manoharan
- Arturo Giordano
- Stephen G. Worthley
Institutions
- University of Copenhagen (DK)
- University of Ulster (GB)
- Erasmus MC (NL)
- The Alfred Hospital (AU)
- Rigshospitalet (DK)
- Hospital Clínico San Carlos (ES)
- Abbott (United States) (US)
- Centro Cardiologico Monzino (IT)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
- Klinik Hirslanden (CH)
- IRCCS Policlinico San Donato (IT)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- Presidio Ospedaliero (IT)
- Royal Victoria Hospital (GB)
- Clinique Pasteur (FR)
- St.-Johannes-Hospital Dortmund (DE)
- GastroZentrum Hirslanden Zürich (CH)
- Royal Victoria Hospital (GB)
- Erasmus University Rotterdam (NL)
- Macquarie University (AU)
Publication Details
- Journal
- JACC: Cardiovascular Interventions
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1016/j.jcin.2025.08.021
- Citations
- 4
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.55
Funders
- St. Jude Medical